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A. fumigatus to 2-drug combination of ABLC, L-AMB 
or C-AMB with CFG and MFG was evaluated by the 
fractional inhibitory concentration index (FICI) 
method. The FICI was determined by a 2-dimensional 
checker-board using the M38-P broth microdilution 
technique proposed by the National Committee for 
Clinical Laboratory Standards for MIC testing of 
conidium-forming filamentous fungi except that the 
MIC was defined as the concentration of the drug that 
provided no visible growth as determined by the 
reduction of tetrazolium compound (MTT assay). The 
FICI was calculated by the formula: FICI=(A, ( 
A,)+(B,tB ) h a w ere A, and B, are the MICs of drugs A 
and B in combination and A, and B, are the MICs of 
drugs A and B. The drug interactions were classified as 
synergistic (FICI<O.S), additive (FICI>O.S but 11) 
indifferent (FICI>l but 12) and antagonistic (FICI>2). 
The FICIs obtained for six two-drug combinations were 
as follows: AMB+CFG=0.42+0.12, ABLC+CFG= 
0.33+0.15, L-AMB+CFG=0.51+0.10, AMB+MFG= 
0.51r0.11, ABLC +MFG=0.47+0.15 and L-AMB+ 
MFG=0.43 kO.14 indicating synergistic interactions in all 
six combinations. These in vitro data suggest that 
conventional and lipid formulations of amphotericin B in 
2-drug combination with the echinocandin caspofungin or 
micafungin is synergistically active against A. fumigatus. 
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Chronic granulomatous disease (CGD) is a rare in- 
herited disorder of the NADPH oxidase complex 
in which neutrophils and monocytes fail to generate 
reactive oxidants such as superoxide anion and hydrogen 
peroxide, key elements in host defense against a variety 
of bacterial and fungal pathogens. 
The overall incidence of fungal infections in CGD has 
been reported at least 20%, with Aspergillus spp. being 
responsible for 78% of all fungal infections. Aspergillosis 
is the most common cause of mortality in these patients 
being responsible for over one third of deaths. Although 
Aspergillus fumigatus is by far the most frequent fungus 
causing infections in immunocompromised patients, A. 
nidulans has also been recognized as a human pathogen. 
Osteomyelitis has occurred in 25% of patients with 
CGD. Aspergillus spp. are the second most common 
cause accounting for approximately 22% of all osteo- 
myelitis cases as recorded in the USA registry. 
We recently treated a CGD patient with femoral 
osteomyelitis due to A. nidulans who had a favorable 
outcome. We review the reported cases of osteomyelitis 
in CGD patients due to this organism and we compare 
them with those due to A. fumigatus. 
Twenty cases of A. nidulans infections have been 
reported in CGD patients to date. In the great majority, 
lungs have been involved, whereas in some patients, 
expansion to neighboring tissues or to remote areas has 
taken place. Fifteen cases of osteomyelitis due to A. 
nidulans have been described in patients with CGD. All 
of them have been males and associated with simul- 
taneous pulmonary infection except for our case. 
Vertebrae and ribs have been found as the sites most 
commonly affected mainly as a result of rapid con- 
tiguous spread from a pulmonary focus. The outcome 
has been generally poor with a mortality rate approach- 
ing 50%. The commonest genetic pattern has been X- 
linked CGD gp91-phox-deficient (60% of 15 cases). 
The management of these cases has been problematic. 
Treatment has required a combined approach with 
surgical debridement, because of the persistent nature of 
the organism, and administration of intensive and pro- 
longed antifungal therapy with amphotericin-B (AMB) 
in the great majority of cases. The addition of a colony- 
stimulating factor or interferon-gamma has appeared to 
have catalytic role in the treatment of these infections. 
By comparison, osteomyelitis due to A. fumigatus has 
been reported in 8 male CGD patients to date.There has 
been no predilection for particular bones; tibia, femur, 
spine and cranium have been some examples. At least 
two multifocal osteomyelitis cases have been described. 
In all cases the outcome has been favourable. However, 
in most of them treatment has required a combined 
approach with surgical debridement and AMB. In some 
cases, interferon-gamma has also been used. 
In conclusion, overall A. fumigatus has been a more 
common pathogen compared with A. nidulans in CGD, 
but A. nidulans has been more virulent and significantly 
more likely to result in death, to involve adjacent bones 
and to cause disseminated disease compared to A. 
fumigatus. Patients with A. nidulans osteomyelitis have 
received longer courses of AMB therapy compared to 
patients with A. fumigatus osteomyelitis. Surgical 
debridement appears to be necessary, but especially in 
A. nidulans osteomyelitis early surgery is imperative. 
Adjunctive use of cytokines in both A. nidulans and A. 
fimigatus osteomyelitis seems to be successful. This 
comparison shows that A. nidulans osteomyelitis carries 
more severe implications than that of A. fumigatus and 
needs more aggressive therapy. 
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